Centyl K Tablets
*Company:
Karo Pharma ABStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 21 November 2025
File name
SmPC-20231027-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.4: addition of warning for hyponatraemia
Section 4.5: addition of interaction with drugs decreasing sodium levels
Section 4.8: update to adverse reaction reporting details
Section 10: update to date of revision
Updated on 21 November 2025
File name
PL 20231027 Centyl K 2.5 mg IE.pdf
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
- Change to MA holder contact details
Free text change information supplied by the pharmaceutical company
Section 2: addition of interaction with medicines which decrease sodium levels
Section 4: update to details for reporting side effects
Section 6: removal of medical information email address
Section 6: update to date of revision
Updated on 21 November 2025
File name
Centyl K 2.5 mg SPC IE.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.4: addition of warning for hyponatraemia
Section 4.5: addition of interaction with drugs decreasing sodium levels
Section 4.8: update to adverse reaction reporting details
Section 10: update to date of revision
Updated on 22 February 2023
File name
PL 20220214 Centyl K 2.5 mg IE.doc.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 21 February 2023
File name
SmPC-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 21 February 2023
File name
PL-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
uploading anew to comply with the correct format
Updated on 17 December 2020
File name
SmPC-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 17 December 2020
File name
PL-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 09 July 2019
File name
SmPC-201903-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 27 March 2019
File name
PL-201903-Centyl K 2.5 mg-ie.pdf
Reasons for updating
- New PIL for new product
Karo Pharma AB
Address:
Box 16184, 103 24 Stockholm, SwedenMedical Information E-mail:
MedinfoIE@karopharma.comTelephone:
+46 10 330 2310Website:
https://www.karopharma.com/Medical Information Direct Line:
+44 (0) 1628 531171Stock Availability:
supply@karopharma.se